You are here

Novo Nordisk raises 2017 forecasts despite continued US price pressure

Thursday, August 10, 2017 - 05:50

Copenhagen

NOVO Nordisk, the world's leading maker of diabetes drugs, reported a better than expected profit on Wednesday driven by new diabetes and obesity drugs, though it said sale prices would remain under pressure in the United States.

The Danish drugmaker shocked markets in

sentifi.com

Market voices on:

Nespresso
Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at btsub.sg/btdeal

Powered by GET.comGetCom